Analyst consensus rating
Olema Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Olema Pharmaceuticals's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $35.50.
Forecast evidence checked November 13, 2026.
Get free Olema Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.52
- Average price target
- $35.50
- High price target
- $59.00
- Low price target
- $13.00
- Low target gap
- +72.9%
- Target upside
- +372.1%
- High target gap
- +684.6%
- Target range width
- 611.7%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Olema Pharmaceuticals?
Olema Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $35.50.
How far are Olema Pharmaceuticals's low and high targets from the recorded price?
The low target implies +72.9%, while the high target implies +684.6%.
How many analysts are included in Olema Pharmaceuticals's consensus?
The verified consensus includes 10 analysts.
How is Olema Pharmaceuticals's target upside or downside calculated?
The average target of $35.50 is divided by the recorded price of $7.52, then one is subtracted to produce +372.1%. This does not guarantee a future return.
When was Olema Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.